Literature DB >> 22874678

Robotic applications in the treatment of diseases of the esophagus.

Andrew Kastenmeier1, Hiram Gonzales, Jon C Gould.   

Abstract

Minimally invasive treatment of esophageal diseases such as gastroesophageal reflux disease, achalasia, and esophageal cancer is associated with many of the benefits observed after the minimally invasive surgery for other diseases (such as symptomatic cholelithiasis) when compared with the open approach. Laparoscopic treatment of these esophageal conditions is technically complex and subject to several inherent limitations. Robotic surgical systems may allow surgeons to overcome many of these obstacles, enabling more widespread adaptation of these techniques.

Entities:  

Mesh:

Year:  2012        PMID: 22874678     DOI: 10.1097/SLE.0b013e318258340a

Source DB:  PubMed          Journal:  Surg Laparosc Endosc Percutan Tech        ISSN: 1530-4515            Impact factor:   1.719


  5 in total

1.  Role of robotic-assisted surgery in benign esophageal diseases.

Authors:  Shireesh Saurabh; Eric Unger; Julie Grossman; Francisco Couto; Namrata Singh; David Scott Lind; Lucian Panait; Andres Castellanos
Journal:  J Robot Surg       Date:  2013-08-15

Review 2.  Review of robotics in foregut and bariatric surgery.

Authors:  Juan P Toro; Edward Lin; Ankit D Patel
Journal:  Surg Endosc       Date:  2014-06-28       Impact factor: 4.584

3.  Robotic resection of a common hepatic artery aneurysm.

Authors:  Chady Salloum; Riccardo Memeo; Daren Subar; Nicola de'Angelis; Stephane Palfi; Daniel Azoulay
Journal:  J Robot Surg       Date:  2014-01-03

4.  Minimally invasive esophagectomy for esophageal cancer in the People's Republic of China: an overview.

Authors:  Chengchu Zhu; Ketao Jin
Journal:  Onco Targets Ther       Date:  2013-03-03       Impact factor: 4.147

5.  RNAi targeting CXCR4 inhibits proliferation and invasion of esophageal carcinoma cells.

Authors:  Tao Wang; Yanfang Mi; Linping Pian; Ping Gao; Hong Xu; Yuling Zheng; Xiaoyan Xuan
Journal:  Diagn Pathol       Date:  2013-06-24       Impact factor: 2.644

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.